Cash & Short-Term Investments

$1.36B

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Cash & Short-Term Investments

Latest reported$1.36Bperiod endingJun 30, 2026

LGND Quarterly Cash & Short-Term Investments ($2.10M → $1.36B)

Quarterly Cash & Short-Term Investments

High-resolution chart · PNG

LGND cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period ending	Cash & Short-Term Investments (USD)
Jun 30, 2026	1,357,758,000
Mar 31, 2026	779,405,000
Dec 31, 2025	733,521,000
Sep 30, 2025	664,522,000
Jun 30, 2025	255,296,000
Mar 31, 2025	208,901,000
Dec 31, 2024	256,165,000
Sep 30, 2024	219,643,000
Jun 30, 2024	226,932,000
Mar 31, 2024	310,593,000
Dec 31, 2023	170,309,000
Sep 30, 2023	190,502,000
Jun 30, 2023	219,041,000
Mar 31, 2023	282,665,000
Dec 31, 2022	211,870,000
Sep 30, 2022	121,407,000
Jun 30, 2022	147,935,000
Mar 31, 2022	203,999,000
Dec 31, 2021	341,108,000
Sep 30, 2021	323,211,000
Jun 30, 2021	301,835,000
Mar 31, 2021	339,207,000
Dec 31, 2020	411,186,000
Sep 30, 2020	795,070,000
Jun 30, 2020	809,880,000
Mar 31, 2020	771,690,000
Dec 31, 2019	1,069,867,000
Sep 30, 2019	1,149,541,000
Jun 30, 2019	1,392,425,000
Mar 31, 2019	1,501,429,000
Dec 31, 2018	764,572,000
Sep 30, 2018	1,111,871,000
Jun 30, 2018	1,016,723,000
Mar 31, 2018	291,888,000
Dec 31, 2017	201,661,000
Sep 30, 2017	202,259,000
Jun 30, 2017	172,627,000
Mar 31, 2017	159,374,000
Dec 31, 2016	141,048,000
Sep 30, 2016	124,115,000
Jun 30, 2016	106,953,000
Mar 31, 2016	113,201,000
Dec 31, 2015	200,219,000
Sep 30, 2015	187,298,000
Jun 30, 2015	181,609,000
Mar 31, 2015	177,225,000
Dec 31, 2014	167,336,000
Sep 30, 2014	186,588,000
Jun 30, 2014	22,027,000
Mar 31, 2014	25,252,000
Dec 31, 2013	15,979,000
Sep 30, 2013	3,271,000
Jun 30, 2013	5,923,000
Mar 31, 2013	5,037,000
Dec 31, 2012	12,381,000
Sep 30, 2012	7,046,000
Jun 30, 2012	10,385,000
Mar 31, 2012	11,294,000
Dec 31, 2011	17,041,000
Sep 30, 2011	12,251,000
Jun 30, 2011	13,441,000
Mar 31, 2011	16,520,000
Dec 31, 2010	22,697,000
Sep 30, 2010	24,069,000
Jun 30, 2010	32,195,000
Mar 31, 2010	39,056,000
Dec 31, 2009	53,232,000
Sep 30, 2009	44,193,000
Jun 30, 2009	55,510,000
Mar 31, 2009	52,604,000
Dec 31, 2008	80,671,000
Sep 30, 2008	71,112,000
Jun 30, 2008	84,996,000
Mar 31, 2008	90,228,000
Dec 31, 2007	94,408,000
Sep 30, 2007	98,392,000
Jun 30, 2007	115,400,000
Mar 31, 2007	410,230,000
Dec 31, 2006	171,848,000
Sep 30, 2006	31,891,000
Jun 30, 2006	60,783,000
Mar 31, 2006	67,705,000
Dec 31, 2005	86,930,000
Sep 30, 2005	73,790,000
Jun 30, 2005	68,274,000
Mar 31, 2005	89,405,000
Dec 31, 2004	112,492,000
Sep 30, 2004	80,407,000
Jun 30, 2004	85,878,000
Mar 31, 2004	97,183,000
Dec 31, 2003	99,034,000
Sep 30, 2003	86,746,000
Jun 30, 2003	41,843,000
Mar 31, 2003	33,983,000
Dec 31, 2002	64,248,000
Sep 30, 2002	35,276,000
Jun 30, 2002	42,556,000
Mar 31, 2002	37,622,000
Dec 31, 2001	37,688,000
Sep 30, 2001	39,424,000